These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30403176)

  • 1. Computational QSAR model combined molecular descriptors and fingerprints to predict HDAC1 inhibitors.
    Shi J; Zhao G; Wei Y
    Med Sci (Paris); 2018 Oct; 34 Focus issue F1():52-58. PubMed ID: 30403176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC1 PREDICTOR: a simple and transparent application for virtual screening of histone deacetylase 1 inhibitors.
    Tinkov OV; Grigorev VY; Grigoreva LD; Osipov VN
    SAR QSAR Environ Res; 2022 Dec; 33(12):915-931. PubMed ID: 36548122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors.
    Chen Y; Cheng F; Sun L; Li W; Liu G; Tang Y
    Ecotoxicol Environ Saf; 2014 Dec; 110():280-7. PubMed ID: 25282305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.
    Patel P; Patel VK; Singh A; Jawaid T; Kamal M; Rajak H
    Curr Comput Aided Drug Des; 2019; 15(2):145-166. PubMed ID: 29732991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition.
    Davis MR; Daggett JJ; Pascual AS; Lam JM; Leyva KJ; Cooper KE; Hull EE
    BMC Cancer; 2016 May; 16():316. PubMed ID: 27188282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.
    Xia Z; Yan A
    Mol Divers; 2017 Aug; 21(3):661-675. PubMed ID: 28484935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors.
    Sirous H; Campiani G; Brogi S; Calderone V; Chemi G
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32331470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
    Yuan Z; Sun Q; Li D; Miao S; Chen S; Song L; Gao C; Chen Y; Tan C; Jiang Y
    Eur J Med Chem; 2017 Jul; 134():281-292. PubMed ID: 28419930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
    Mazzio EA; Soliman KF
    Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation.
    Krishna S; Lakra AD; Shukla N; Khan S; Mishra DP; Ahmed S; Siddiqi MI
    J Biomol Struct Dyn; 2020 Jul; 38(11):3280-3295. PubMed ID: 31411124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lazy learning-based QSAR classification study for screening potential histone deacetylase 8 (HDAC8) inhibitors.
    Cao GP; Arooj M; Thangapandian S; Park C; Arulalapperumal V; Kim Y; Kwon YJ; Kim HH; Suh JK; Lee KW
    SAR QSAR Environ Res; 2015; 26(5):397-420. PubMed ID: 25986171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Study of Target Engagement Assays for HDAC1 Inhibitor Profiling.
    Asawa RR; Zakharov A; Niehoff T; Chitsaz A; Jadhav A; Henderson MJ; Simeonov A; Martinez NJ
    SLAS Discov; 2020 Mar; 25(3):253-264. PubMed ID: 31662025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR modeling to design selective histone deacetylase 8 (HDAC8) inhibitors.
    Cao GP; Thangapandian S; Son M; Kumar R; Choi YJ; Kim Y; Kwon YJ; Kim HH; Suh JK; Lee KW
    Arch Pharm Res; 2016 Oct; 39(10):1356-1369. PubMed ID: 27542119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel two-step QSAR modeling work flow to predict selectivity and activity of HDAC inhibitors.
    Zhao L; Xiang Y; Song J; Zhang Z
    Bioorg Med Chem Lett; 2013 Feb; 23(4):929-33. PubMed ID: 23321563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods.
    Li R; Tian Y; Yang Z; Ji Y; Ding J; Yan A
    Mol Divers; 2023 Jun; 27(3):1037-1051. PubMed ID: 35737257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational identification of novel histone deacetylase inhibitors by docking based QSAR.
    Nair SB; Teli MK; Pradeep H; Rajanikant GK
    Comput Biol Med; 2012 Jun; 42(6):697-705. PubMed ID: 22521374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.
    Abdelkarim H; Neelarapu R; Madriaga A; Vaidya AS; Kastrati I; Karumudi B; Wang YT; Taha TY; Thatcher GRJ; Frasor J; Petukhov PA
    ChemMedChem; 2017 Dec; 12(24):2030-2043. PubMed ID: 29080240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.